1 Result(s)

Article

Estimating the Impact of Delayed Access to Oncology Drugs on Patient Outcomes in Canada

New requirements in Canada’s pricing processes for patented drugs may exacerbate delays in regulatory and reimbursement reviews. This study seeks to better understand the impact of any additional delays on non...

Jackie Vanderpuye-Orgle, Daniel Erim, Yi Qian, Devon J. Boyne… in Oncology and Therapy (2022)